AI-generated analysis. Always verify with the original filing.
Omada Health reported Q4 2025 revenue of $76 million (up 58% YoY) and full-year revenue of $260 million (up 53% YoY), achieving positive net income of $5 million in Q4 and positive Adjusted EBITDA of $6 million for the year. The company issued 2026 guidance for revenue of $312-322 million and Adjusted EBITDA of $7-15 million.
Event Type
Disclosure
Mandatory
Variant
8-K
of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the
Financial Statements and Exhibits (d) Exhibits. Ex. Number Ex. Description 99.1 Press Release 104 Cover Page Interactive Data File (embedded within the Inline X